Although the total expression levels of NOX5 are low in individual patients (Fig. 13A), the increases or decreases vary from −192% to 426% (Fig. 13B), thereby suggesting that mutations and alterations in signal transduction pathways in lung adenocarcinoma markedly affect NOX5 regulation. Here, NOX5 is linked to lung adenocarcinoma.